Patent details
300713 Product Name: Daclatasvir en farmaceutisch aanvaardbare zouten daarvan, in het bijzonder daclatasvir dihydrochloride
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300713
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP2049522
- Status:
- Invalid because the basic patent has lapsed before the expiration date or has been revoked
- Application number:
- 300713
- Procedural language:
- Dutch
- First Applicant Residence Country:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/14/939/001-004
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 26/08/2014
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 20/01/2015
- First Marketing Authorization date:
- 26/08/2014
- Grant date:
- 29/12/2015
- Activation date:
- 09/08/2027
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 09/11/2015
- SPC/SPC Extension Expiration Date:
- 25/08/2029
- Lapsed By Expiration Date:
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 10/01/2019
- Name:
- BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANY
- Address:
- Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)
Historical Applicant/holder
- From:
- 20/01/2015
- To:
- 10/01/2019
- Name:
- Bristol-Myers Squibb Holdings Ireland
- Address:
- Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)
Agent
- Name:
- ir. F.A. Geurts c.s.
- From:
- 20/01/2015
- Address:
- Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 14/21
- Publication date:
- 07/04/2021
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- CO
- Journal edition number:
- 13/19
- Publication date:
- 27/03/2019
- Description:
- Changes in the Netherlands Patent Register
3
- Bulletin Heading:
- SPC
- Journal edition number:
- 53/15
- Publication date:
- 30/12/2015
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
- Bulletin Heading:
- SPC
- Journal edition number:
- 46/15
- Publication date:
- 11/11/2015
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
- Bulletin Heading:
- SPC
- Journal edition number:
- 2015/05
- Publication date:
- 28/01/2015
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name
- Deed Number:
- RC201900044A
- Date Registered:
- 10/01/2019
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANY
- Address:
- Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 31/08/2027
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 1600 Euro
- Last Annual Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 30/12/2015 | SPC Documents | Certificate SPC | 1 | /3/1/7/0/0/0400300713/docs/300713_2_supplprotectioncertificate20201022125025883.pdf | ||
| 30/12/2015 | Outgoing Correspondence | Outgoing Letter | 1 | /3/1/7/0/0/0400300713/docs/300713_4_outgoingcorrespondence20201022124820398.pdf | ||
| 29/10/2015 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /3/1/7/0/0/0400300713/docs/300713_3_incomingcorrespondencepaper20151208124159393.pdf | ||
| 05/02/2015 | Outgoing Correspondence | Outgoing Letter | 1 | /3/1/7/0/0/0400300713/docs/300713_5_outgoingcorrespondence20150205.pdf | ||
| 21/01/2015 | Outgoing Correspondence | Outgoing Letter | 1 | /3/1/7/0/0/0400300713/docs/300713_9_outgoingcorrespondence20150121.pdf | ||
| 20/01/2015 | SPC Documents | Summary of the characteristics of the product | 51 | /3/1/7/0/0/0400300713/docs/300713_0_supplprotectioncertificate20201022123120265.pdf | ||
| 20/01/2015 | Application Form | First filed application form | 3 | /3/1/7/0/0/0400300713/docs/300713_1_applicationform20150120.pdf | ||
| 20/01/2015 | SPC Documents | Annex SPC | 1 | /3/1/7/0/0/0400300713/docs/300713_6_supplprotectioncertificate20201022122116543.pdf | ||
| 20/01/2015 | Incoming Correspondence Paper | Accompanying letter incoming document | 2 | /3/1/7/0/0/0400300713/docs/300713_7_incomingcorrespondencepaper20150120.pdf | ||
| 20/01/2015 | SPC Documents | Marketing Authorization SPC | 3 | /3/1/7/0/0/0400300713/docs/300713_8_supplprotectioncertificate20201022123510473.pdf |